Securian Asset Management Inc. Trims Stake in DaVita Inc. (NYSE:DVA)

Securian Asset Management Inc. reduced its position in shares of DaVita Inc. (NYSE:DVA) by 11.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,252 shares of the company’s stock after selling 300 shares during the quarter. Securian Asset Management Inc.’s holdings in DaVita were worth $337,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of DVA. Amundi increased its holdings in shares of DaVita by 116.4% in the 4th quarter. Amundi now owns 446,386 shares of the company’s stock valued at $68,726,000 after acquiring an additional 240,126 shares during the period. FMR LLC increased its holdings in shares of DaVita by 659.9% in the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after acquiring an additional 154,061 shares during the period. Glenmede Trust Co. NA increased its holdings in shares of DaVita by 731.6% in the 3rd quarter. Glenmede Trust Co. NA now owns 123,269 shares of the company’s stock valued at $20,207,000 after acquiring an additional 108,446 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of DaVita by 17.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company’s stock valued at $99,846,000 after acquiring an additional 92,014 shares during the period. Finally, Strategic Financial Concepts LLC purchased a new position in shares of DaVita in the 4th quarter valued at $9,371,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

DaVita Stock Performance

Shares of DVA opened at $149.27 on Wednesday. The stock has a 50-day moving average of $158.80 and a two-hundred day moving average of $157.61. DaVita Inc. has a one year low of $125.64 and a one year high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The stock has a market cap of $11.94 billion, a P/E ratio of 13.90, a P/E/G ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, research analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Ratings Changes

DVA has been the topic of a number of analyst reports. Barclays lifted their price target on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. Cowen restated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 target price on DaVita in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.